Teon Therapeutics
PrivateLast Round
Series A
Feb 22, 2021
Est. Valuation
$63.7M
Total Funding Raised
$37.27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Teon Therapeutics operates in Healthcare & Life Sciences and is based in Redwood City, California. Its latest recorded funding round was a Series A round in February 2021.
Teon Therapeutics is a biotechnology company that develops single-target small molecules aimed at restoring antitumor immunity and inhibiting cancer cell growth.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Teon Therapeutics Comparables
Compare Teon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pathios Therapeutics | 83% | |
| Isosceles Pharmaceuticals | 79% | |
| Arcus Biosciences | 78% |
For institutional investors. Book with your work email.
Teon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 22, 2021 | ||||
| Debt | Apr 15, 2020 | ||||
| Seed | Jan 24, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Teon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series A, Seed |
| Kaitai Capital | Series A, Seed |
| Northern Light Venture Capital | Series A, Seed |
| Oceanpine Capital | Series A |
| Oriza Ventures | Series A |
| Oriza Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 144% MoM, reaching 2K.
- Feb 22, 2021
$30M round led by Oceanpine Capital
For institutional investors. Book with your work email.
Teon Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Teon Therapeutics's valuation, stock price, and market status.
Is Teon Therapeutics a public or private company?
Teon Therapeutics is a private company.
What is the current stock price of Teon Therapeutics?
Teon Therapeutics is a private company, so its shares have no public market price. Caplight tracks Teon Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Teon Therapeutics worth (valuation)?
Teon Therapeutics's valuation is estimated at $63.7M based on funding round data.
Can I buy Teon Therapeutics stock?
Teon Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Teon Therapeutics's last funding round?
Teon Therapeutics's most recent funding round was Series A on February 22, 2021.
Who are the main investors in Teon Therapeutics?
Key investors in Teon Therapeutics include Northern Light Venture Capital, Oceanpine Capital.
Will Teon Therapeutics IPO soon?
No public IPO plans have been announced for Teon Therapeutics.
How can I track Teon Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Teon Therapeutics's shares on secondary markets.